Literature DB >> 31874059

A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings.

Yu-Jin Kwon1,2, Da-Hye Son3, Tae-Ha Chung2,4, Yong-Jae Lee3.   

Abstract

Since ancient times, licorice, the root of Glycyrrhiza glabra, has been known to have a wide spectrum of therapeutic effects. Glycyrrhizin is cleaved to glycyrrhizic acid, which is subsequently converted to glycyrrhetic acid by human intestinal microflora. Glycyrrhetic acid is a potent inhibitor of 11β-hydroxysteroid dehydrogenase (11β-HSD) and performs a range of corticosteroid-like activities. The pharmacologic effects of licorice contribute to its anti-inflammatory, antioxidative, anti-allergenic, and antimicrobial properties. Licorice has been used to treat liver disease, gastrointestinal disorders, oral disease, and various skin disorders and has been used in gum, candy, herbs, alcoholic beverages, and food supplements. Licorice and its extracts, especially glycyrrhizin, can be taken orally, through the skin (in the form of gels and oils), and intravenously. Licorice demonstrates mineralocorticoid-like activity not only by inhibiting 11β-HSD2, but also by binding to a mineralocorticoid receptor, leading to potentially adverse risks of mineralocorticoid-like overactivity. Chronic use of licorice can lead to hypokalemia and hypertension, and some people are more sensitive to licorice exposure. Based on clinical trials, this review summarizes the positive effects of licorice and other reported side effects.

Entities:  

Keywords:  11-hydroxysteroid dehydrogenase; glycyrrhizic acid; glycyrrhizin; licorice

Mesh:

Substances:

Year:  2019        PMID: 31874059     DOI: 10.1089/jmf.2019.4459

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  21 in total

Review 1.  A Review of Glycyrrhiza glabra (Licorice) Effects on Metabolic Syndrome.

Authors:  Fatemeh Jafari; Mohsen Jafari; Ali Tafazoli Moghadam; Seyed Ahmad Emami; Tannaz Jamialahmadi; Amir Hooshang Mohammadpour; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Network Pharmacology and In Vivo Experimental Validation to Uncover the Renoprotective Mechanisms of Fangji Huangqi Decoction on Nephrotic Syndrome.

Authors:  Jiazhen Yin; Dongrong Yu; Lichan Mao; Caifeng Zhu; Jin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

Review 3.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.

Authors:  Camila Dos Santos Leite; Gabriel Alves Bonafé; Juliana Carvalho Santos; Carlos Augusto Real Martinez; Manoela Marques Ortega; Marcelo Lima Ribeiro
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 4.  Toxicity as prime selection criterion among SARS-active herbal medications.

Authors:  Franz Oesch; Barbara Oesch-Bartlomowicz; Thomas Efferth
Journal:  Phytomedicine       Date:  2021-01-28       Impact factor: 5.340

5.  Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.

Authors:  Lukas van de Sand; Maren Bormann; Mira Alt; Leonie Schipper; Christiane Silke Heilingloh; Eike Steinmann; Daniel Todt; Ulf Dittmer; Carina Elsner; Oliver Witzke; Adalbert Krawczyk
Journal:  Viruses       Date:  2021-04-02       Impact factor: 5.048

Review 6.  Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases.

Authors:  Meenakshi Rajendiran; Harsh M Trivedi; Dandan Chen; Praveen Gajendrareddy; Lin Chen
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

7.  Assessment of General Toxicity of the Glycyrrhiza New Variety Extract in Rats.

Authors:  Dong-Gu Kim; Jeonghoon Lee; Wonnam Kim; Hyo-Jin An; Jong-Hyun Lee; Jaeki Chang; Sa-Haeng Kang; Young-Jae Song; Yong-Deok Jeon; Jong-Sik Jin
Journal:  Plants (Basel)       Date:  2021-06-01

Review 8.  Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.

Authors:  Changchao Huan; Yao Xu; Wei Zhang; Tingting Guo; Haochun Pan; Song Gao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 9.  Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries: A narrative review.

Authors:  Minji Cho; Youngmin Bu; Jae-Woo Park; Hasanur Rahman; Seok-Jae Ko
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

Review 10.  The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.

Authors:  Stephanie M Boas; Kathlene L Joyce; Rita M Cowell
Journal:  Antioxidants (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.